A Comparision of Several Formats of Amphotericin B as an Inhaled Antifungal Prophylaxis

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2225-2226

  SanMartin E ^a   Morales, P ^a   Monte, E ^a   Vicente, R ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG SAFETY; DRUG STABILITY; DRUG TOLERABILITY; HUMAN; LUNG MYCOSIS; LUNG TRANSPLANTATION; NURSE; PRIORITY JOURNAL; PROPHYLAXIS;

ADMINISTRATION, INHALATION; AMPHOTERICIN B; ANTIFUNGAL AGENTS; HUMANS; LUNG TRANSPLANTATION; MYCOSES; POSTOPERATIVE COMPLICATIONS;

EID: 68949198059     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.018     Document Type: Article

References (5)

1. Solé A., Morant P., Salavert M., et al., Valencia Lung Transplant Group. Aspergillus fumigatus in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect 11 (2005) 359
2. Calvo V., Borro J.M., Morales P., et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Trasplant Group. Chest 115 (1999) 1301
3. Monforte V., Román A., Gavaldá J., et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant 20 (2001) 1274
4. Monforte V., Ussetti P., López R., et al. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety. J Heart Lung Transplant 28 (2009) 170
5. Corcoran T.E., Venkataramanan R., Mihelc K.M., et al. Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant 6 (2006) 2765